Kumiai Chemical announced a significant upward revision of its consolidated earnings forecast for the second quarter of the fiscal year ending October 2026, projecting sales of \u00a5102.9 billion (+10.9% YoY), operating profit of \u00a510.4 billion (+70.5%), and net income attributable to owners of the parent of \u00a58.7 billion (+97.7%).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4996","jir_company_name":"Kumiai Chemical Industry Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-06-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4996-20260609-01.pdf","jir_short_summary":"Kumiai Chemical announced a significant upward revision of its consolidated earnings forecast for the second quarter of the fiscal year ending October 2026, projecting sales of \u00a5102.9 billion (+10.9% YoY), operating profit of \u00a510.4 billion (+70.5%), and net income attributable to owners of the parent of \u00a58.7 billion (+97.7%).","jir_summary":"### Overview of Business Performance\nKumiai Chemical has significantly upwardly revised its consolidated earnings forecast for the second quarter of the fiscal year ending October 2026. The company now projects sales of \u00a5102.9 billion (+10.9% compared to the previous forecast), operating profit of \u00a510.4 billion (+70.5%), ordinary income of \u00a513.7 billion (+67.1%), and net income attributable to owners of the parent of \u00a58.7 billion (+97.7%). This increase is mainly due to accelerated shipments in the pesticides and agricultural-related business segments, driven by sales promotions ahead of the entry of generic products of Axive into the U.S. market, as well as strong performance in the chemical products business. The full-year earnings estimates remain unchanged, considering the impact of the Middle East situation.\n\n### Outlook and Impact\nWhile future trends in business performance may warrant revisions, the company currently maintains its original full-year forecast. It anticipates recording impairment losses and restructuring costs as extraordinary losses, aiming for further improvement and stable business progression. The company will continue proactive sales promotion and cost management, considering the possibility that prolonged geopolitical issues in the Middle East may impact its operations.","jir_financial_highlights":"Sales: \u00a5102,900 million (Compared to previous forecast +10.9%)\nOperating profit: \u00a510,400 million (Compared to previous forecast +70.5%)\nOrdinary income: \u00a513,700 million (Compared to previous forecast +67.1%)\nNet income attributable to owners of the parent: \u00a58,700 million (Compared to previous forecast +97.7%)","jir_category":"","jir_hashtags":"#KumiaiChemical, #EarningsGuidanceRevision, #JapanStocks","jir_key_figures":"Sales: \u00a5102.9 billion (+10.9% vs. previous forecast)\nOperating profit: \u00a510 billion (+70.5%)\nNet income attributable to owners of the parent: \u00a58.7 billion (+97.7%)","jir_meta_title":"\u3010Kumiai Chemical\u3011Revision of Earnings Guidance for the First Half of 2026 | Sales of \u00a5102.9 billion (+10.9%)","jir_meta_description":"Kumiai Chemical announced a significant upward revision of its consolidated earnings forecast for the second quarter of the fiscal year ending October 2026, projecting sales of \u00a5102.9 billion and net income of \u00a58.7 billion. Analysis of future outlooks is also provided.","jir_og_title":"\u3010Kumiai Chemical\u3011Revision of Earnings Guidance for the First Half of 2026 | Sales of \u00a5102.9 billion","jir_og_description":"Kumiai Chemical revised its earnings forecast for the second quarter of the fiscal year ending October 2026, expecting sales of \u00a5102.9 billion and net income of \u00a58.7 billion. Future outlooks are also detailed.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16678,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-62385","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n